TAS1R3 and inflammatory bowel disease: Among the 1,697 upregulated DEGs (FDR P < 0.001) in patients with IBD, TAS1R3 expression was increased in the intestinal tract (Fig. 8c, d), as was the expression of TNFA, IL1B, and IL8 (Fig. 8c).